Psoriasis Treatment Market

Psoriasis Treatment Market Research Report: Forecast up to 2024
Global Psoriasis Treatment Market - Overview
This report on the Psoriasis Treatment market analyzes the current and future scenario of the global
market. Approval of new biologics, increase in access for the treatment in developing market,
increase in the number of psoriasis patients, are boosting the growth of the global Psoriasis
Treatment market. Increase in the incidence of Psoriasis and skin disorders, and novel pipeline
drugs are some of the factors expected to drive the growth of global Psoriasis Treatment market
during the forecast period.
The Psoriasis Treatment market report comprises an elaborate executive summary, which includes
market snapshot that provides information about various segments. It also provides information and
data analysis of the global market with respect to the segments based on products, distribution
channel, therapy type and geography. A detailed qualitative analysis of drivers and restraints, and
opportunities has been provided in the market overview section.
Additionally, the section comprises Porter’s Five Forces Analysis to help understand the
competitive landscape in the market. This section also provides market attractiveness analysis in
terms of geography and market share analysis by key players, thus presenting a thorough analysis of
the overall competitive scenario in the global Psoriasis Treatment market.
Companies Mentioned in the Report
The report also profiles major players in the global Psoriasis Treatment market based on various
attributes such as company overview, financial overview, product portfolio, business strategies,
SWOT analysis, and recent developments. Major players profiled in this report include Amgen Inc.,
Eli Lilly and Company, Novartis AG, Merck & Co., Inc., Johnson & Johnson, Pfizer, Inc.,
AstraZeneca, AbbVie Inc., LEO Pharma A/S and Biogen.

This exhaustive report includes a 360° view of the Psoriasis Treatment Market. Browse
through this 178-page report to know what factors will shape the market during the period
2016-2024
http://www.transparencymarketresearch.com/psoriasis-treatment-market.html
Global Psoriasis Treatment Market - Segmentation
In this report, the market segments have been analyzed based on availability of approved products,
cost-effectiveness, and preference for technological systems by physicians and patients. The market
size and forecast for each of these segments have been provided for the period from 2014 to 2024,
along with their respective CAGRs for the forecast period from 2016 to 2024, considering 2015 as
the base year.
Based on product type, the market has been segmented into TNF Inhibitors, Vitamin D analogues or
its combination, Interleukin Blockers and Others. Interleukin blockers segment is likely to be the
most attractive segment in the near future due to its increasing use and its ability to act selectively
by targeting the proteins. The segment is expected to grow at a highest CAGR rate during forecast
period.
Based on Therapy type, the global Psoriasis Treatment market has been segmented into Topical
Therapeutic Drugs, Systemic Therapeutic Drugs, Combinations of therapies & others. The market
segments have been extensively analyzed based on increase in demand for the therapies, availability
of the drug products, and cost of therapy and severity of the disease.
Different types of distribution channels are responsible for making the psoriasis treatment available
in the market. The distribution channels are Hospital pharmacy, Retail pharmacy and the online
sales. Under the distribution channel segment, hospital pharmacy plays a major role followed by
retail pharmacy and online sales.
Geographically, the global Psoriasis Treatment market has been categorized into five major regions
and the key countries in the respective region: North America (U.S. and Canada), Europe (U.K.,
Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, Japan, China, Australia &
New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America)
and Middle East & Africa (South Africa, Saudi Arabia, and Rest of Middle East & Africa).
Request a brochure of this report to know what opportunities will emerge in the rapidly
evolving Psoriasis Treatment Market during 2016- 2024
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=17960

About Us
Transparency Market Research (TMR) is a market intelligence company, providing global
business information reports and services. Our exclusive blend of quantitative forecasting and
trends analysis provides forward-looking insight for thousands of decision makers. TMR’s
experienced team of analysts, researchers, and consultants, use proprietary data sources and various
tools and techniques to gather, and analyze information. Our business offerings represent the latest
and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals,
chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and
technology. These reports provide in-depth analysis and deep segmentation to possible micro levels.
With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide
clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com